CG MedTech Statistics

Total Valuation

CG MedTech has a market cap or net worth of KRW 96.86 billion. The enterprise value is 68.49 billion.

Market Cap	96.86B
Enterprise Value	68.49B

Important Dates

The last earnings date was Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

CG MedTech has 103.26 million shares outstanding. The number of shares has increased by 22.48% in one year.

Current Share Class	103.26M
Shares Outstanding	103.26M
Shares Change (YoY)	+22.48%
Shares Change (QoQ)	-36.11%
Owned by Insiders (%)	0.42%
Owned by Institutions (%)	n/a
Float	46.81M

Valuation Ratios

The trailing PE ratio is 61.22.

PE Ratio	61.22
Forward PE	n/a
PS Ratio	2.55
PB Ratio	1.11
P/TBV Ratio	1.17
P/FCF Ratio	99.49
P/OCF Ratio	32.93
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 29.03, with an EV/FCF ratio of 70.35.

EV / Earnings	45.34
EV / Sales	1.80
EV / EBITDA	29.03
EV / EBIT	104.32
EV / FCF	70.35

Financial Position

The company has a current ratio of 4.69, with a Debt / Equity ratio of 0.04.

Current Ratio	4.69
Quick Ratio	3.36
Debt / Equity	0.04
Debt / EBITDA	1.58
Debt / FCF	3.82
Interest Coverage	3.45

Financial Efficiency

Return on equity (ROE) is 1.78% and return on invested capital (ROIC) is 0.49%.

Return on Equity (ROE)	1.78%
Return on Assets (ROA)	0.42%
Return on Invested Capital (ROIC)	0.49%
Return on Capital Employed (ROCE)	0.67%
Revenue Per Employee	362.19M
Profits Per Employee	14.39M
Employee Count	105
Asset Turnover	0.39
Inventory Turnover	1.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.51% in the last 52 weeks. The beta is -0.62, so CG MedTech's price volatility has been lower than the market average.

Beta (5Y)	-0.62
52-Week Price Change	-20.51%
50-Day Moving Average	960.22
200-Day Moving Average	1,121.98
Relative Strength Index (RSI)	45.81
Average Volume (20 Days)	359,390

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CG MedTech had revenue of KRW 38.03 billion and earned 1.51 billion in profits. Earnings per share was 15.32.

Revenue	38.03B
Gross Profit	16.84B
Operating Income	640.78M
Pretax Income	1.60B
Net Income	1.51B
EBITDA	2.34B
EBIT	640.78M
Earnings Per Share (EPS)	15.32

Full Income Statement

Balance Sheet

The company has 32.23 billion in cash and 3.71 billion in debt, giving a net cash position of 28.51 billion or 276.13 per share.

Cash & Cash Equivalents	32.23B
Total Debt	3.71B
Net Cash	28.51B
Net Cash Per Share	276.13
Equity (Book Value)	87.27B
Book Value Per Share	839.51
Working Capital	41.48B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.94 billion and capital expenditures -1.97 billion, giving a free cash flow of 973.51 million.

Operating Cash Flow	2.94B
Capital Expenditures	-1.97B
Free Cash Flow	973.51M
FCF Per Share	9.43

Full Cash Flow Statement

Margins

Gross margin is 44.29%, with operating and profit margins of 1.68% and 3.97%.

Gross Margin	44.29%
Operating Margin	1.68%
Pretax Margin	4.22%
Profit Margin	3.97%
EBITDA Margin	6.16%
EBIT Margin	1.68%
FCF Margin	2.56%

Dividends & Yields

CG MedTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.48%
Shareholder Yield	-22.48%
Earnings Yield	1.56%
FCF Yield	1.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 5, 2022. It was a forward split with a ratio of 5.

Last Split Date	Aug 5, 2022
Split Type	Forward
Split Ratio	5

Scores

CG MedTech has an Altman Z-Score of 3.83.

Altman Z-Score	3.83
Piotroski F-Score	n/a